Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Kubota Pharmaceutical Holdings Co., Ltd.
No Price
Closing Price XTKS 01.05.2026:
94,00 JPY
01.05.2026 05:41
Current Prices from Kubota Pharmaceutical Holdings Co., Ltd.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Tokyo
4596.T
JPY
01.05.2026 05:41
94,00 JPY
2,00 JPY
+2,17 %
Share Float & Liquidity
Free Float86,43 %
Shares Float55,17 M
Shares Outstanding63,83 M
Company Profile for Kubota Pharmaceutical Holdings Co., Ltd. Share
Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices in the ophthalmic field worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device, a home-based and patient self-monitoring optical coherence tomography devices to treat wet age-related macular degeneration and diabetic macular edema, which brings retinal edema and reduction in visual acuity; and wearable device for myopia control. The company was founded in 2002 and is based in Tokyo, Japan.
